In July 2016, a resilient, joyful 5-year-old named Bryce took part in a first-of-its-kind clinical trial at Children’s National Health System in Washington, D.C. As an infant, Bryce had been diagnosed with a particularly severe form of sickle cell disease and had already suffered at least four strokes related to the…

Read more…